To determine whether N249S-PTG mutant form could modify the glycogen accumulation phenotype in a neuronal cell line, we reduced the expression of laforin in a SH-SY5Y human neuroblastoma cells by shRNA (Figure 5A) and transfected these cells with either wild type or N249S-PTG mutant forms. The gene discussed is EPM2A; the disease is neuroblastoma.